Amy Sprole, MD
Plastic Surgery · Wichita, KSNPI 1326119066
Payments from drug & device makers
What this record shows
AbbVie accounts for 67.6% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $3,186 and has fallen 94.3% since, to $181 in 2025.
Across 146 payments — averaging $38.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Galderma Laboratories, L.p.$593
- TELA Bio, Inc.$298
- Sientra, Inc.$237
- Mentor Worldwide LLC$218
- Novo Nordisk$157
- plus $343 from 8 others
What the payments were for
- Food & beverage$2,99153%
- Gifts$2,70047%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 80 | $3,847 |
| Galderma Laboratories, L.p. | 25 | $593 |
| TELA Bio, Inc. | 4 | $298 |
| Sientra, Inc. | 9 | $237 |
| Mentor Worldwide LLC | 9 | $218 |
| Novo Nordisk | 4 | $157 |
| Smith+Nephew | 5 | $73 |
| Johnson & Johnson | 3 | $66 |
| Convatec Inc. | 1 | $60 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $48 |
| Apollo Endosurgery US Inc | 2 | $35 |
| Integra Lifesciences Corporation | 1 | $30 |
| Osiris Therapeutics Inc. | 1 | $17 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,691 in reported general payments places this provider in the 75th percentile of 42 plastic surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Scopolamine | 37 | $493 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 50 | $415 |
| Cephalexin | 58 | $246 |
| Ondansetron OdtOndansetron | 58 | $161 |
| Acyclovir | 14 | $49 |
| Omeprazole | 16 | $11 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Wichita
- James RiegerWichita$17K
- James ShawWichita$6K
- Kenton SchoonoverWichita$3K
- Richard DesplinterWichita$1K
- Vanessa VogeWichita$738
- Gerald NelsonWichita$59
- Andrea KoegelWichita$21
- David ZamierowskiOverland Park$11.9M
- Daniel BortnickLeawood$26K
- Dana BalderramaTopeka$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.